Thailand's Most LGBTQ+-Inclusive Healthcare (2026)

Thailand is one of the world's leading medical-tourism destinations, drawing patients from across the region and beyond. For many LGBTQ+ travellers, the journey is deeply personal — gender-affirming care, sexual-health services including HIV prevention and treatment, and fertility support are among the reasons people cross borders to be treated here.

That makes one question worth asking out loud: which healthcare companies operating in Thailand are actually building inclusive cultures? PrideShow's annual ranking scores companies on LGBTQ+ inclusion, and this healthcare spin-off pulls together two groups that matter most to the sector — the global pharmaceutical and health multinationals, and Thailand's SET-listed hospital groups.

Global pharma & healthcare companies in Thailand

These are multinational pharmaceutical and health companies (MNCs) scored on the PrideShow Inclusion Index — a 0–100 measure weighted toward signals a global company operating in Thailand can demonstrate, such as international DEI frameworks, employee networks, and group-level inclusion commitments. Every company in this group sits in the Gold tier.

The spread here is tight: from Johnson & Johnson at 73 down to four companies — AstraZeneca, GSK, Novartis, and Sanofi — tied at 67. All seven clear the Gold threshold, a reflection of how widely large pharmaceutical groups have adopted international inclusion frameworks at the corporate level.

Thai SET-listed hospital groups

These are Thailand's publicly listed hospital operators (PLCs), scored on the PrideShow ESG Score — a separate 0–100 methodology built around SET-listed disclosure: non-discrimination policy, supply-chain diversity, community investment, and reporting transparency. Because the methodology and scale differ from the Inclusion Index, this is a distinct ranking and the two groups should never be read against each other.

BDMS (Bangkok Dusit Medical Services) tops this group at 69 and is the single Gold-tier hospital operator on the list. The remaining six — Thonburi Healthcare Group, Bumrungrad International Hospital, Praram9 Hospital, Bangkok Chain Hospital, Chularat Hospital, and Ramkhamhaeng Hospital — land in the Silver tier, from 63 down to 47.

What inclusive care looks like in practice

A corporate inclusion score and a good clinical experience are not the same thing — but the day-to-day signals a patient can actually feel are worth naming. For LGBTQ+ patients, inclusive care in practice tends to look like:

• Trans-aware, pronoun-respecting intake — forms and front-desk staff that don't force people into the wrong box.
• Same-sex partners recognised in consent, decision-making, and visiting arrangements.
• Non-judgmental sexual-health services, including HIV prevention such as PrEP, testing, and treatment.
• Staff who treat gender-affirming and fertility journeys as routine care, not as something to question.

None of these are captured by an ESG filing or a DEI framework alone. They show up at the bedside — which is exactly why a corporate score should inform your shortlist, not finish your decision.

How the scoring works

Two methodologies are at play, and keeping them separate is the point. Global pharmaceutical and health multinationals are scored on the PrideShow Inclusion Index, which leans on signals a multinational can demonstrate — international DEI frameworks, employee networks, and group-level commitments. Thai SET-listed hospital groups are scored on the PrideShow ESG Score, which is built around the disclosure expected of a listed Thai company: non-discrimination policy, supply-chain diversity, community investment, and reporting transparency.

All of these scores are published live on the PrideShow directory and are recomputed as new disclosures and signals come in. They are corporate-inclusion measures — a useful, transparent starting point for understanding which companies are doing the institutional work, and a deliberately incomplete picture of what any individual patient will experience.